Hypoglycaemic activity of Bauhinia holophylla through GSK3-β inhibition and glycogenesis activation

Hypoglycaemic activity of Bauhinia holophylla through GSK3-β inhibition and glycogenesis activation

Context: Bauhinia L. species, including Bauhinia holophylla (Bong.) Steud. (Fabaceae), have traditionally been used to treat diabetes. Bauhinia is a complex botanical genus, and the indiscriminate use of the diverse Bauhinia species is reflected in the experimental divergence of their medicinal pote...

Full description

Saved in:
Bibliographic Details
Main Authors: Nathalia Ap. De Paula Camaforte, Luiz Leonardo Saldanha, Priscilla Maria Ponce Vareda, João M. Rezende-Neto, Mario R. Senger, Aislan Q. Delgado, Henrique J. N. Morgan, Natalia Moretti Violato, Laís Goyos Pieroni, Anne Lígia Dokkedal, Floriano P. Silva-Júnior, José Roberto Bosqueiro
Format: article
Language:EN
Published: Taylor & Francis Group 2019
Subjects:
antidiabetic
fabaceae
flavonoid-o-glycosides
liver
plasma lipids
Therapeutics. Pharmacology
RM1-950
Online Access:https://doaj.org/article/c92011cc897643339a978a5d7ca2b0dd
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/c92011cc897643339a978a5d7ca2b0dd

Similar Items